Global Health (Medanta) reported a 15% year-over-year revenue growth and a 14% year-over-year EBITDA increase (excluding Noida) for Q2 FY2026. Key drivers include increased patient volumes and realizations. The company’s Noida hospital commenced operations in September 2025. Expansion projects continue with new beds added in Patna and ongoing developments in Mumbai and Guwahati.
Financial Highlights for Q2 FY2026
Global Health Limited (Medanta) announced robust financial results for the second quarter of fiscal year 2026:
- Total Income: INR 11,189 million, up 14.8% year-over-year.
- EBITDA (excluding Noida): INR 2,804 million, a 13.7% increase year-over-year, with a margin of 25.2%.
- Profit After Tax: INR 1,584 million, representing a 21.1% year-over-year growth.
Medanta Noida, which began operations in September 2025, contributed revenue of INR 39 million but incurred an EBITDA loss of INR 197 million for the quarter.
Operational Performance
Several key operational metrics contributed to the strong performance:
- Occupied bed days increased by 7.7% year-over-year.
- In-patient count rose by 12.7%, and out-patient count grew by 14.9% year-over-year.
- International Patients Revenue increased significantly by 48.5% year-over-year to INR 762 million.
During the quarter, 37 new beds were added at Patna, bringing the total new bed addition for H1 FY26 to 57.
Expansion and Projects
Medanta is actively pursuing expansion projects:
- Guwahati, Assam: Land acquisition and possession completed, with Bhoomi Poojan held on October 31, 2025.
- Mumbai: Project cost estimated at ~INR 15,300 million. Additional FSI approval received, increasing bed capacity to 750.
- Noida: Commenced Phase 1 with 226 beds operational as of Q2 FY26.
Capex Plan
The company has outlined a capex plan for the next five years, with a total outlay of approximately INR 41,200 million. This includes:
- Maintenance Capex: Estimated at INR ~4,500 million.
- Project Capex: Estimated at INR ~36,700 million, to be funded through debt and internal accruals.
Source: BSE
